About Actin-related protein 10
Actin-related protein 10 (ACTR10) is a protein
from Homo sapiens identified by UniProt accession
Q9NZ32, 417 residues long.
MolForge cross-references it against 0 known binders and
26 disease associations.
Target properties
| Protein name | Actin-related protein 10 |
| UniProt accession | Q9NZ32 |
| Gene | ACTR10 |
| Organism | Homo sapiens |
| Length | 417 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (26)
Diseases linked to this target (Open Targets).
- alcohol consumption measurement · score 0.16
- smoking status measurement · score 0.12
- Immature Reticulocyte Fraction Measurement · score 0.11
- Red cell distribution width · score 0.09
- mean platelet volume · score 0.08
- mean corpuscular hemoglobin concentration · score 0.07
- alcohol use disorder measurement · score 0.07
- triglyceride measurement · score 0.07
- BMI-adjusted waist-hip ratio · score 0.06
- reticulocyte measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NZ32-F1 | alphafold | PREDICTED | 83.30 | — |
Amino-acid sequence (417 residues)
MPLYEGLGSG GEKTAVVIDL GEAFTKCGFA GETGPRCIIP SVIKRAGMPK PVRVVQYNIN TEELYSYLKE FIHILYFRHL LVNPRDRRVV IIESVLCPSH FRETLTRVLF KYFEVPSVLL APSHLMALLT LGINSAMVLD CGYRESLVLP IYEGIPVLNC WGALPLGGKA LHKELETQLL EQCTVDTSVA KEQSLPSVMG SVPEGVLEDI KARTCFVSDL KRGLKIQAAK FNIDGNNERP SPPPNVDYPL DGEKILHILG SIRDSVVEIL FEQDNEEQSV ATLILDSLIQ CPIDTRKQLA ENLVVIGGTS MLPGFLHRLL AEIRYLVEKP KYKKALGTKT FRIHTPPAKA NCVAWLGGAI FGALQDILGS RSVSKEYYNQ TGRIPDWCSL NNPPLEMMFD VGKTQPPLMK RAFSTEK
Explore Actin-related protein 10 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets